April 21, 2026, 12 – 1 pm EST
Sex differences, bilingual experience, and cognitive reserve in mild cognitive impairment
Speaker: Noelia Calvo
Although women are disproportionately affected by Alzheimer’s disease and bilingualism has been associated with enhanced cognitive reserve, the combined influence of sex and bilingual experience on dementia-related resilience is not well understood. In a sample of 335 older adults with mild cognitive impairment from a Canadian cohort, we investigated the interplay between biological sex, bilingualism, and circulating sex hormones in relation to cognitive performance and Alzheimer’s disease biomarkers. Structural equation modeling was used to generate an individualized resilience score, which was then examined in relation to diagnostic status and blood-based indicators of neurodegeneration.
Bilingual individuals demonstrated greater resilience compared to monolinguals, and among bilinguals, men showed higher resilience scores than women. Elevated resilience was linked to reduced likelihood of Alzheimer’s disease and lower concentrations of p-tau181, neurofilament light, and glial fibrillary acidic protein (GFAP). Verbal episodic memory played a central mediating role connecting sex and bilingualism to overall cognitive functioning. These results highlight distinct resilience patterns shaped by sex and language background in mild cognitive impairment, suggesting a possible resilience advantage among older bilingual men.
Please note that registration is required to attend. Click here to register.
Past webinars
What are you looking for?
“You have to be there”: Emotional labor, cultural ethics, and the realities of Black families of people with dementia in Canada during COVID-19
February 17, 2026
Caring for the family caregiver: Lived experiences of family caregivers and mindfulness-based interventions for older adult caregivers of persons with dementia
January 20, 2026
Developing Dementia Decoded: Acute Care Dementia Strategy at The Ottawa Hospital
December 16, 2025
Using plasma biomarkers to estimate the prevalence of Alzheimer’s Disease pathology in COMPASS-ND
November 17, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research
May 20, 2025
The content of this webinar is based on this scientific review paper: Smith E. et al. (2025), Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research. Journal of Prevention of Alzheimer’s Disease.
Visit this page for frequently asked questions about the use of new medications for Alzheimer’s disease in the Canadian healthcare system
Dementia-related apathy: Recent advances in diagnosis and treatment
April 29, 2025
This presentation is based on this scientific review paper: Lanctôt K.L. et al. (2023) Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders. International Journal of Geriatric Psychiatry. Feb., 38(2):e5882.
Consult this page for an infographic tool for clinicians on distinguishing apathy from depression in neurocognitive disorders
Brain rhythms, proteinopathy, and neurochemistry along the Alzheimer’s disease continuum
February 5, 2025
Food on the brain: Nutrition in Indigenous communities
December 10, 2024
Navigating risk-taking in the presence of anosognosia: Decision-making capacity challenges in Alzheimer’s disease
December 3, 2024
Modest dietary carbohydrate restriction to sustain healthy cognitive aging
October 8, 2024
Sex and Gender research in CCNA: A sampling of current projects and future directions
April 23, 2024
Why sensory-cognitive research in aging and dementia requires a multi-disciplinary approach
April 9, 2024
